FDA approves Waskyra for Wiskott-Aldrich syndrome
by Lori SolomonThe U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).Waskyra is
Updated on: December 27,2025
FDA approves Waskyra for Wiskott-Aldrich syndrome
by Lori SolomonThe U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).Waskyra is
Updated on:December 27,2025
